Citadel Advisors - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 8 filers reported holding NOVELION THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$181,000
+58.8%
249,260
+71.0%
0.00%
Q2 2019$114,000
-19.1%
145,737
+27.3%
0.00%
Q1 2019$141,000
+354.8%
114,487
+214.5%
0.00%
Q4 2018$31,000
-49.2%
36,400
+85.2%
0.00%
Q4 2017$61,00019,6550.00%
Other shareholders

There were no reported owners of NOVELION THERAPEUTICS INC in Q4 2019.

NameSharesValueWeighting ↓
View complete list of NOVELION THERAPEUTICS INC shareholders